The pharmacology and kinetics of ecto-nucleotidases in the perilymphatic compartment of the guinea-pig cochlea

Hear Res. 1998 Mar;117(1-2):71-80. doi: 10.1016/s0378-5955(98)00004-5.

Abstract

This study investigated the characteristics of ecto-nucleotidases in tissues lining the perilymphatic cavity of the cochlea. The perilymphatic space of the isolated guinea-pig cochlea was maintained with oxygenated artificial perilymph (AP) perfused at a rate of 100 microl/min. Following AP perfusion, either adenosine triphosphate (ATP), adenosine diphosphate (ADP) or adenosine monophosphate (AMP) was introduced into scala tympani, and perfusion arrested for 2 min for substrate incubation with cochlear tissues. Effluent collected from the cochlea was assayed for adenine nucleotide metabolites by reverse-phase high-performance liquid chromatography (RP-HPLC). Extracellular ATP and ADP were rapidly and sequentially hydrolysed to adenosine by Ca2+/Mg2+-dependent and Ca2+/Mg2+-independent enzymatic mechanisms. The degradation of extracellular ATP, ADP and AMP occurred in the presence of intact tissues, as demonstrated by the limited lactate dehydrogenase (LDH) activity (0-2.2%). ATPase activity was not affected by inhibitors of intracellular ATPases (oligomycin, ouabain, N-ethylmaleimide, 100 microM NaN3) and non-specific alkaline phosphatase (beta-glycerophosphate). The hydrolysis of ATP was inhibited by 5 mM NaN3, suramin, ATPgammaS, La3+ and CTP, the hydrolysis of ADP by beta,gamma-imidoATP, and AMP degradation by alpha,beta-methyleneADP. Ecto-ATPase, ecto-ADPase and ecto-5'-nucleotidase followed Michaelis-Menten hyperbolic kinetics, with estimated Km values of 2282 microM, 6619 microM and 881 microM, respectively. Our results indicate the presence of considerable ecto-nucleotidase activity within scala tympani of the cochlea, and support its role as the terminating mechanism for P2 receptor signalling known to occur in the cochlea. A competition plot is consistent with ATP and ADP degradation mediated by the same enzyme (ecto-ADP diphosphohydrolase) with two different catalytic sites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5'-Nucleotidase / antagonists & inhibitors
  • 5'-Nucleotidase / metabolism*
  • Adenosine Diphosphate / metabolism
  • Adenosine Diphosphate / pharmacology
  • Adenosine Monophosphate / metabolism
  • Adenosine Monophosphate / pharmacology
  • Adenosine Triphosphatases / antagonists & inhibitors
  • Adenosine Triphosphatases / metabolism*
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Antigens, CD
  • Antimetabolites / pharmacology
  • Apyrase / antagonists & inhibitors
  • Apyrase / metabolism*
  • Ca(2+) Mg(2+)-ATPase / metabolism
  • Cell Survival / drug effects
  • Chromatography, High Pressure Liquid
  • Cochlea / cytology
  • Cochlea / drug effects
  • Cochlea / enzymology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Guinea Pigs
  • Hydrolysis
  • In Vitro Techniques
  • Kinetics
  • L-Lactate Dehydrogenase / metabolism
  • Male
  • Perilymph / drug effects
  • Perilymph / enzymology*

Substances

  • Antigens, CD
  • Antimetabolites
  • Enzyme Inhibitors
  • Adenosine Monophosphate
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • L-Lactate Dehydrogenase
  • 5'-Nucleotidase
  • Adenosine Triphosphatases
  • Ca(2+) Mg(2+)-ATPase
  • ectoATPase
  • Apyrase
  • CD39 antigen